Serum Vascular Endothelial Growth Factor as a Possible Prognostic Indicator in Sarcoidosis

Lung

Volumn 181, Issue 5, 2003, Pages 259-265

  Sekiya, M ^a   Ohwada, A ^a,b   Miura, K ^a   Takahashi, S ^a   Fukuchi, Y ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Tokyo Metropol Koto Geriatric M ^*  (Japan)

Author keywords

Prognosis; Sarcoidosis; VEGF

Indexed keywords

CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE; VASCULOTROPIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD LEVEL; CANCER REGRESSION; CANCER STAGING; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; MALE; METASTASIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RADIODIAGNOSIS; SARCOIDOSIS;

ADRENAL CORTEX HORMONES; ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; PROGNOSIS; REMISSION, SPONTANEOUS; SARCOIDOSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 0142249372     PISSN: 03412040     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00408-003-1028-8     Document Type: Article

References (19)

1. Nagai S, Shigematsu M, Hamada K, Izumi T (1999) Clinical courses and prognoses of pulmonary sarcoidosis. Curr Opin Pulm Med 5:293-298
2. Dvorak HF, Brown LF, Detmar M, Dvorak AM (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146: 1029-1039
3. Takano S, Yoshii Y, Kondo S, Suzuki H, Maruno T, Shirai S, Nose T (1996) Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res 56:2185-2190
4. Griga T, Tromm A, Spranger J, May B (1998) Increased serum levels of vascular endothelial growth factor in patients with inflammatory bowel disease. Scand J Gastroenterol 33:504-508
5. Matsuyama W, Hashiguchi T, Matsumuro K, Iwami F, Hirotsu Y, Kawabata M, Arimura K, Osame M (2000) Increased serum level of vascular endothelial growth factor in pulmonary tuberculosis. Am J Respir Crit Care Med 162:1120-1122
6. Li CG, Reynolds I, Ponting JM, Holt PJ, Hillarby MC, Kumar S (1998) Serum levels of vascular endothelial growth factor (VEGF) are markedly elevated in patients with Wegener's granulomatosis. Br J Rheumatol 37:1303-1306
7. Bragado R, Bello E, Requena L, Renedo G, Texeiro E, Alvarez MV, Castilla MA, Caramelo C (1999) Increased expression of vascular endothelial growth factor in pyogenic granulomas. Acta Derm Venereol 79:422-425
8. Tolnay E, Kuhnen C, Voss B, Wiethege T, Muller KM (1998) Expression and localization of vascular endothelial growth factor and its receptor flt in pulmonary sarcoidosis. Virchows Arch 432:61-65
9. Hunninghake GW, Costabel U, Ando M, Baughman R, Cordier JF, du Bois R, Eklund A, Kitaichi M, Lynch J, Rizzato G, Rose C, Selroos O, Semenzato G, Sharma OP (1999) ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders, Sarcoidosis Vasc Diffuse Lung Dis 16:149-173
10. Meyer KC, Cardoni A, Xiang ZZ (2000) Vascular endothelial growth factor in bronchoalveolar lavage from normal subjects and patients with diffuse parenchymal lung disease. J Lab Clin Med 135:332-338
11. Iwai K, Sekiguti M, Hosoda Y, DeRemee RA, Tazelaar HD, Sharma OP, Maheshwari A, Noguchi TI (1994) Racial difference in cardiac sarcoidosis incidence observed at autopsy. Sarcoidosis 11:26-31
12. Yamaguchi E, Itoh A, Hizawa N, Kawakami Y (2001) The gene polymorphism of tumor necrosis factor-beta, but not that of tumor necrosis factor-alpha, is associated with the prognosis of sarcoidosis. Chest 119:753-761
13. Petrek M, Drabek J, Kolek V, Zlamal J, Welsh KI, Bunce M, Weigl E, Du Bois R (2000) CC chemokine receptor gene polymorphisms in Czech patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 162:1000-1003
14. Pietinalho A, Furuya K, Yamaguchi E, Kawakami Y, Selroos O (1999) The angiotensin-converting enzyme DD gene is associated with poor prognosis in Finnish sarcoidosis patients. Eur Respir J 13:723-726
15. Tomita H, Sato S, Matsuda R, Sugiura Y, Kawaguchi H, Niimi T, Yoshida S, Morishita M (1999) Serum lysozyme levels and clinical features of sarcoidosis. Lung 177:161-167
16. Muller-Quernheim J (1998) Serum markers for the staging of disease activity of sarcoidosis and other interstitial lung diseases of unknown etiology. Sarcoidosis Vasc Diffuse Lung Dis 15:22-37
17. Costabel U, Teschler H (1997) Biochemical changes in sarcoidosis. Clin Chest Med 18:827-842
18. Katada J, Muramatsu M, Hayashi I, Tsutsumi M, Konishi Y, Majima M (2002) Significance of vascular endothelial cell growth factor up-regulation mediated via a chymase-angiotensin-dependent pathway during angiogenesis in hamster sponge granulomas. J Pharmacol Exp Ther 302:949-956
19. Costabel U (2001) Sarcoidosis: clinical update. Eur Respir J (suppl) 32:56s-68s